Skip to main content

Advertisement

Table 1 Adult patient characteristics at enrollment into HIV Care, by enrollment year

From: Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study

  Total 2006-2007 2008-2009 2010-2011 p-value1
  n = 93,418 %2 n = 34,528 %2 n = 35,242 %2 n = 23,648 %2
Age category          <0.0001
15-24 yrs 14,997 16.1 5,361 15.5 5,687 16.1 3,949 16.7  
25-39 yrs 57,160 61.2 21,519 62.3 21,532 61.1 14,109 59.7  
40-49 yrs 14,675 15.7 5,490 15.9 5,438 15.4 3,747 15.8  
50+ yrs 6,586 7.1 2,158 6.3 2,585 7.3 1,843 7.8  
Sex          0.0002
Male 36,906 39.5 13,917 40.3 13,857 39.3 9,132 38.6  
Female 56,512 60.5 20,611 59.7 21,385 60.7 14,516 61.4  
Religion          <0.0001
Orthodox 56,616 60.6 21,398 62.0 21,260 60.3 13,958 59.0  
Muslim 16,145 17.3 5,142 14.9 6,157 17.5 4,846 20.5  
Protestant 14,205 15.2 5,538 16.0 5,358 15.2 3,309 14.0  
Other/Unknown 6,452 6.9 2,450 6.8 2,467 6.6 1,535 6.1  
Marital status          <0.0001
Never Married 12,591 13.5 4,828 14.0 4,520 12.8 3,243 13.7  
Married/Living together 48,218 51.6 16,780 48.6 18,653 52.9 12,785 54.1  
Separated/Divorced 16,971 18.2 6,360 18.4 6,289 17.9 4,322 18.3  
Widowed 11,165 12.0 4,633 13.4 3,996 11.3 2,536 10.7  
Other/Unknown 4,473 4.8 1,927 5.6 1,784 5.1 762 3.2  
Education          <0.0001
No Education 27,547 29.5 9,309 27.0 10,697 30.4 7,541 31.9  
Primary 34,178 36.6 12,768 37.0 12,794 36.3 8,616 36.4  
Secondary 20,943 22.4 8,667 25.1 7,603 21.6 4,673 19.8  
Tertiary 5,565 6.0 1,606 4.7 2,118 6.0 1,841 7.8  
Other/Unknown 5,185 5.6 2,178 6.3 2,030 5.8 977 4.1  
Point of entry into care         <0.0001
PITC 34,566 37.0 9,538 27.6 14,425 40.9 10,603 44.8  
VCT 29,128 31.2 13,162 38.1 9,713 27.6 6,253 26.4  
Other Hospital/HC 12,930 13.8 6,418 18.6 4,142 11.8 2,370 10.0  
Community 1,143 1.2 483 1.4 370 1.0 290 1.2  
Unknown/missing 15,651 16.8 4,927 14.3 6,592 18.7 4,132 17.5  
Transferred in 1,607 1.7 526 1.5 535 1.5 546 2.3 <0.0001
WHO Stage          <0.0001
Stage I 23,979 26 6,891 20 9,767 28 7,321 31  
Stage II 16,595 18 5,272 15 6,655 19 4,668 20  
Stage III 33,072 35 13,299 39 12,023 34 7,750 33  
Stage IV 6,456 7 3,395 10 1,800 5 1,261 5  
Missing 13,316 14 5,671 16 4,997 14 2,648 11  
CD4+ cell count (cells/mm3)        
Median(IQR) 183 (87–342) 158 (76–293) 195 (93–360) 208 (98–376) <0.0001
<100 19,392 21 8,017 23 6,814 19 4,561 19  
100-199 16,818 18 6,557 19 6,087 17 4,174 18  
200-350 15,077 16 5,006 14 5,809 16 4,262 18  
350+ 16,364 18 4,612 13 6,650 19 5,102 22  
Missing 25,767 28 10,336 30 9,882 28 5,549 23  
TB screening at enrollment         <0.0001
Yes 54,033 57.8 11,275 32.7 23,505 66.7 19,253 81.4  
No/not recorded 39,385 42.2 23,253 67.3 11,737 33.3 4,395 18.6  
TB treatment at enrollment         <0.0001
Yes 8,445 9.0 3,091 9.0 2,969 8.4 2,385 10.1  
No/not recorded 84,973 91.0 31,437 91.0 32,273 91.6 21,263 89.9  
Cotrimoxazole at enrollment         <0.0001
Yes 59,652 63.9 20,032 58.0 22,870 64.9 16,750 70.8  
No/not recorded 33,766 36.1 14,496 42.0 12,372 35.1 6,898 29.2  
Facility type          <0.0001
Primary (11 sites) 4,844 5.2 1,316 3.8 1,934 5.5 1,594 6.7  
Secondary/tertiary (45 sites) 88,574 94.8 33,212 96.2 33,308 94.5 22,054 93.3  
Setting          <0.0001
Urban city (25 sites) 57,904 62.0 22,693 65.7 21,408 60.7 13,803 58.4  
Semi-urban (21 sites) 29,219 31.3 10,492 30.4 11,442 32.5 7,285 30.8  
Rural (10 sites) 6,295 6.7 1,343 3.9 2,392 6.8 2,560 10.8  
Initiated ART          
Yes 53,300 57.1 21,920 63.5 19,296 54.8 12,084 51.1 <0.0001
No 40,118 42.9 12,608 36.5 15,946 45.2 11,564 48.9  
  1. 1p-values based on chi-squared test for any difference across groups over time. see text for specific tests for trend.
  2. 2categorical percentages may not total exactly 100% due to roundoff errors.